Forte Biosciences (FBRX) Misses Q3 EPS by 433c
Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($4.54), $4.33 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.
Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($4.54), $4.33 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.